Undertreatment in nAMD

Macuject's role in addresing undertreatment

Evolving Technology Capturing nAMD Under-treatment

Macuject uses machine learning artificial intelligence for analysing macular optical coherence tomography images to find and measure intraretinal and subretinal fluid volumes. In doing so, the aim is to guide treatment decisions which ultimately will help reduce the emerging issue of preventable vision loss due to the under-treatment of neovascular age-related macular degeneration (nAMD).

For the full article, please visit the mivision journal website:


Just click the button and we’ll contact with you in the next few hours

Request a demo